ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print January 23, 2008
Eur Respir J 2008, doi:10.1183/09031936.00081707
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
31/5/943    most recent
09031936.00081707v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bayley, D.L.
Right arrow Articles by Stockley, R.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayley, D.L.
Right arrow Articles by Stockley, R.A.


ORIGINAL ARTICLE

Validation of Assays for Inflammatory Mediators in Exhaled Breath Condensate

D.L. Bayley 1, H. Abusriwil 1, A. Ahmad 1, R.A. Stockley 2

1 Dept of Medicine, University of Birmingham
2 Queen Elizabeth Hospital, Birmingham


   Abstract

The use of exhaled breath condensate as a tool for non-invasive assessment of lung inflammation is becoming commonplace. Many authors use commercial ELISA kits to measure inflammatory mediators within EBC. However, the very low concentrations of mediators within EBC are often below the commercially validated concentration range of the relevant ELISA and crucially the linear part of the sigmoid standard curve. This study seeks to validate a series of assays for use in EBC and to compare the results in EBC with those from matched sol-phase sputum samples.

The following mediators: Leukotriene B4, interleukin 8, secretory leukoprotease inhibitor, alpha-1-antitrypsin were measured by ELISA. Myeloperoxidase was measured by chromogenic substrate assay.

Mediator concentrations reached lower limit of quantification in only one assay (alpha-1-antitrypsin) in 19.6% of subjects, whilst mediator concentrations reached lower limit of detection in three assays (leukotriene B4, interleukin 8 and alpha-1-antitrypsin in 31%, 6.5% and 61% of subjects respectively). No significant correlations were present between any mediators in exhaled breath condensate and sol-phase sputum.

These results indicate that care must be exercised when interpreting mediator measurements in exhaled breath condensate and that assays must be validated at concentrations relevant to those found within the biological fluid.

Keywords:  Alpha-1-Antitrypsin, Exhaled Breath Condensate, Interleukin 8, Leukotriene B4, Myeloperoxidase, Secretory leukoprotease inhibitor




This article has been cited by other articles:


Home page
ChestHome page
J.-L. Corhay, M. Henket, D. Nguyen, B. Duysinx, J. Sele, and R. Louis
Leukotriene B4 Contributes to Exhaled Breath Condensate and Sputum Neutrophil Chemotaxis in COPD
Chest, October 1, 2009; 136(4): 1047 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
I. Horvath, Z. Lazar, N. Gyulai, M. Kollai, and G. Losonczy
Exhaled biomarkers in lung cancer
Eur. Respir. J., July 1, 2009; 34(1): 261 - 275.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. Sapey, D. Bayley, A. Ahmad, and R. Stockley
The validation of assays used to measure biomarkers in exhaled breath condensate
Eur. Respir. J., November 1, 2008; 32(5): 1408 - 1409.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the European Respiratory Society.